Tissue Plasminogen Activator (tPA) - Uses - Hematology - Pharmacology

preview_player
Показать описание

- With Picmonic, get your life back by studying less and remembering more. Medical and Nursing students say that Picmonic is the most comprehensive and effective way to bridge learning and test prep...
Disclaimer: I use affiliate links....

This is known as thrombolytic therapy, useful for myocardial infarction and ischemic strokes, but contraindicated in hemorrhagic strokes (due to increased risk of bleeding).

There are absolute contraindications as well as relative contraindications to fibrinolytic therapy (tPA, alteplase, streptokinase,...etc).

Рекомендации по теме
Комментарии
Автор

I am old enough to have used both Streptokinase and TPA for acute myocardial infarction. Probably treated 20 plus before angioplasty took over. You had to use Streptokinase right. 1.5 million units over 30 minutes, instead of 60 minutes...this was rock and roll Strepto from protocols developed in New Zealand. The guys would groan, " I feel terrible ", roll onto their sides, vomit, and... reperfuse. I loved it, much more dramatic than the slow TPA protocol. Being in a community hospital about 60 miles from tertiery centers, I still drill with the TPA protocols because sometimes the choppers don't fly and on those days ground transport ain't humming either! Cheers!

davidmbeckmann
Автор

شكرا كتير انت سبب نجاحي بامتحان الascp بعد انقطاع ١١سنه

hindhind
Автор

NCLEX-RN tip: contraindication of tPA starts at 13:48

ronnazhou
Автор

im watching all 121 videos rn for USMLE

ionictotalwar
Автор

what other intravenous medication for the stroke except TPA please ?

shang
Автор

@MedicosisPerfectionalis can plasmin break chronic blood clots which has organized or calcified in artery?

sivav
Автор

Where can i find your video on stroke ?

barjees
Автор

"uh- we have another hour to.." "s-h-u-t. u-p."

ronnazhou
Автор

Why we lysis fibrin by plasmin but on otherhand we need fibrin for cloting

A_b_loveA_b_love
Автор

So here's a question for you, if Pharmaceutical companies don't increase prices to 'what the market will bear', why do patented drugs in Europe cost only about 20% of what they cost in the USA? Even drugs off patent are about half as expensive in Europe. Answer... Because the pharmaceutical companies are limited in how much they can charge in Europe and other countries too. Not so in the USA, where they raise the prices to what the market will bear, lol... I do appreciate your point though about why localized fibrinogen drugs are more expensive!

leggy